Terrence C. Kearney, Director at ACCELERON PHARMA INC (XLRN), sold 75,000 shares at $117.82 ($9.0M) on 2020-10-12, disclosed to the SEC on 2020-10-13.
Open-market sale of $9.0M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.82 | 2,200 | $259K | 2.9% |
| 2 | $117.82 | 2,200 | $259K | 2.9% |
| 3 | $119.11 | 18,177 | $2.2M | 24.2% |
| 4 | $119.11 | 18,177 | $2.2M | 24.2% |
| 5 | $119.78 | 16,210 | $1.9M | 21.7% |
| 6 | $119.78 | 16,210 |
| $1.9M |
| 21.7% |
| 7 | $120.57 | 913 | $110K | 1.2% |
| 8 | $120.57 | 913 | $110K | 1.2% |
| Total | $119.36 avg | 75,000 | $9.0M | 100% |
| Filing → |
| VRTX | SELL | 2015-04-29 | $8.8M | — | Filing → |
| HSP | SELL | 2010-12-17 | $10.3M | — | Filing → |
| HSP | SELL | 2010-10-25 | $1.7M | — | Filing → |